Cargando…

Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib

Anti-angiogenesis therapy plays a vital role in the treatment of tumors, with anlotinib as its representative targeted drug. Anlotinib is a novel oral tyrosine kinase inhibitor (TKI) with inhibitory effects on tumor growth tumor angiogenesis. In Phase III clinical trials, anlotinib demonstrated bett...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shiting, Wang, Hongqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657757/ https://www.ncbi.nlm.nih.gov/pubmed/38024530 http://dx.doi.org/10.2147/DDDT.S426898

Ejemplares similares

Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
por: Rizzoli, René, et al.
Publicado: (2011)

Efficacy and Safety of Anlotinib for Elderly Patients with Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions
por: Song, Peng-Fei, et al.
Publicado: (2020)

Adverse Drug Reactions
por: Turner, Paul
Publicado: (1988)

Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal
por: Shrestha, Sunil, et al.
Publicado: (2020)

Progress, Challenges, and Prospects of Research on the Effect of Gene Polymorphisms on Adverse Reactions to Opioids
por: Zhao, Jinsong, et al.
Publicado: (2022)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer
por: Tan, Tingfei, et al.
Publicado: (2022)

Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303
por: Si, Xiaoyan, et al.
Publicado: (2019)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Adverse drug reactions in the elderly
por: Brahma, Dhriti K., et al.
Publicado: (2013)

Textbook of Adverse Drug Reactions
por: George, Charles F.
Publicado: (1992)

Digging Up the Human Genome: Current Progress in Deciphering Adverse Drug Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014)

Controversies in the Management of Cutaneous Adverse Drug Reactions
por: Manchanda, Yashpal, et al.
Publicado: (2018)

Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs
por: Wu, Ting-Hui, et al.
Publicado: (2018)

Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation
por: King, Charlotte, et al.
Publicado: (2020)

Drug–drug–gene interactions and adverse drug reactions
por: Malki, Mustafa Adnan, et al.
Publicado: (2019)

The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis
por: Shen, Fangcheng, et al.
Publicado: (2023)

Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
por: Hu, Nanlin, et al.
Publicado: (2021)

Focus on headache as an adverse reaction to drugs
por: Ferrari, Anna, et al.
Publicado: (2009)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
por: Zhang, Xi, et al.
Publicado: (2021)

Cellular in vitro diagnosis of adverse drug reactions
por: Möbs, Christian, et al.
Publicado: (2014)

Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
por: Cacabelos, Ramón, et al.
Publicado: (2021)

Expert consensus of management of adverse drug reactions with anaplastic lymphoma kinase tyrosine kinase inhibitors
por: Zhou, F., et al.
Publicado: (2023)

HLA Association with Drug-Induced Adverse Reactions
por: Fan, Wen-Lang, et al.
Publicado: (2017)

Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs
por: Moore, Nicholas, et al.
Publicado: (2015)

Editorial: Assessment and management of adverse drug reactions in oncology
por: Tsai, Ping-Feng, et al.
Publicado: (2023)

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs †
por: Noyes, James D., et al.
Publicado: (2021)

Ayurvedic management of adverse drug reactions with Shvitrahara Varti
por: Jadav, Hasmukh R., et al.
Publicado: (2013)

Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma
por: Li, Shenglong
Publicado: (2021)

Adverse Drug Reactions
por: Criado, Paulo Ricardo
Publicado: (2016)

Clinical and economic burden of adverse drug reactions
por: Sultana, Janet, et al.
Publicado: (2013)

Vertigo/dizziness as a Drugs’ adverse reaction
por: Chimirri, Serafina, et al.
Publicado: (2013)

Adverse Drug Reactions. Their Prediction, Detection and Assessment
Publicado: (1973)

The Progressive Multifocal Leukoencephalopathy Consortium as a Model for Advancing Research and Dialogue on Rare Severe Adverse Drug Reactions
por: Peterson, Ilse S., et al.
Publicado: (2019)

Improving reporting of adverse drug reactions: Systematic review
por: Molokhia, Mariam, et al.
Publicado: (2009)

Learning Lessons from Adverse Drug Reactions in Children
por: Sammons, Helen M., et al.
Publicado: (2016)

Adverse Drug Reactions in Norway: A Systematic Review
por: Vaismoradi, Mojtaba, et al.
Publicado: (2019)

HLA‐associated adverse drug reactions ‐ scoping review
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Adverse drug reaction management in hospital settings: review on practice variations, quality indicators and education focus
por: Aung, Ar Kar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mle7t6f0adsh9v70h7mbdrg0qq